Clinical Research and ICH GCP Training Services in Japan

Online, November 5, 2010 (Newswire.com) - London,UK Headquartered MNC,Helix Research Center Ltd has announced Clinical Research and ICH GCP (International Conference on Harmonisation,Good Clinical Practices) Training Services for the Global Clinical Trial Sponsors exploring the possibility of placing one or more of their Trials in Japan.

Helix firmly believes that Japan is one of the most enterprising Countries in the World;in view of the existing State of the Art Healthcare Infrastructure and all other prerequisites needed to expedite the Clinical Trial Projects within Timelines.

The measures being taken by the Japanese Ministry of Health,Labour and Welfare (MHLW) inroder to Reinforce and /or Promote Clinical Research in Japan by Introducing '5 Yearly Clinical Trial Activation Plan 'is remarkable and the contribution being made by 'Japan Medical Association Center for Clinical Trials'-JMACCT, to support the Clinical Research Investigators and Clinical Trial Sites by creating network of Trial Sites across the country is Unique in the World.

It is an established fact that Japan was one of Initiators of ICH,that was formed to 'Harmonise' the Clinical Research Process in Europe,United States and Japan and World in general.The Japanese Regulatory Authority,PMDA ( Pharmaceuticals and Medical Devices Agency)is committed to assuring Protection of Human Rights by introducing a 'Safety Triangle'.

Helix Research Center will be exploring Collaborations with like minded Individuals,Groups and Professional Associations to learn more about Clinical Trial Process in Japan and contribute its share for better Healthcare.